1. Home
  2. ABVC vs MDBH Comparison

ABVC vs MDBH Comparison

Compare ABVC & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ABVC BioPharma Inc.

ABVC

ABVC BioPharma Inc.

HOLD

Current Price

$1.05

Market Cap

35.6M

Sector

Health Care

ML Signal

HOLD

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

HOLD

Current Price

$3.77

Market Cap

36.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABVC
MDBH
Founded
2015
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
35.6M
36.7M
IPO Year
2009
2022

Fundamental Metrics

Financial Performance
Metric
ABVC
MDBH
Price
$1.05
$3.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
151.7K
6.6K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
7.14
N/A
EPS
N/A
N/A
Revenue
$509,589.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.06
Revenue Growth
N/A
N/A
52 Week Low
$0.88
$2.75
52 Week High
$4.02
$5.50

Technical Indicators

Market Signals
Indicator
ABVC
MDBH
Relative Strength Index (RSI) 36.72 63.76
Support Level $0.88 $3.16
Resistance Level $1.71 $3.80
Average True Range (ATR) 0.14 0.18
MACD -0.02 0.02
Stochastic Oscillator 7.14 62.74

Price Performance

Historical Comparison
ABVC
MDBH

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

Share on Social Networks: